ID’s Hollingshead Eye Center Invests in Optos Technology

Hollingshead Eye Center in Boise, Idaho, has announced it has invested in Optos 200Tx-AF ultra-widefield imaging technology, according to a news release.

Advertisement

 

The technology is intended to help detect the earliest signs of retinal diseases, and provide a digital record to help monitor the progression of the conditions.

 

“Optos 200Tx-AF® ultra-widefield imaging technology has been designed specifically for ophthalmologists and vitreoretinal specialists,” said Mark Hollingshead, MD, in the release. “The typical manual technique for examining the retina reveals only 10-12 percent of it at one time. The 200Tx-AF provides a panoramic map of more than 80 percent of the retina and gives us a new avenue of information that we haven’t had until now.”

 

Dr. Hollingshead opened Hollingshead Eye Center in 1994.

 

Related Articles on Ophthalmology:

Study: Patients on Statins at Lower Risk for Glaucoma

Ophthalmologist on the Move: Dr. George Baerveldt Joins CA’s NVISION Laser Eye Centers

Bausch + Lomb Receives FDA Approval of LOTEMAX Gel

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.